Intensity Therapeutics, Inc.INTSNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank42
3Y CAGR-50.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-50.4%/yr
Quarterly compound
Percentile
P42
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 2.81% |
| Q2 2025 | -23.48% |
| Q1 2025 | 25.45% |
| Q4 2024 | 32.83% |
| Q3 2024 | 5.74% |
| Q2 2024 | 3.48% |
| Q1 2024 | -360.95% |
| Q4 2023 | 81.50% |
| Q3 2023 | -2042.43% |
| Q2 2023 | 73.48% |
| Q1 2023 | 44.88% |
| Q4 2022 | -59.38% |
| Q3 2022 | 23.06% |
| Q2 2022 | 10.16% |
| Q1 2022 | 48.28% |
| Q4 2021 | -91.51% |
| Q3 2021 | -19.25% |
| Q2 2021 | -4.38% |
| Q1 2021 | 29.99% |
| Q4 2020 | 0.00% |